<?xml version='1.0' encoding='utf-8'?>
<record xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
			<header>
				<identifier>oai:aavptbiennial-ojs-tamu.tdl.org:article/54</identifier>
				<datestamp>2022-06-28T19:01:00Z</datestamp>
				<setSpec>aavptbiennial:S2</setSpec>
			</header>
			<metadata>
<oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/  http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en">Clinical Efficacy of an Oral Long-Acting Analgesic with a Human Abuse Deterrent in Perioperative Dogs</dc:title>
	<dc:creator xml:lang="en">Fitzgerald, A.</dc:creator>
	<dc:creator xml:lang="en">KuKanich, B.</dc:creator>
	<dc:creator xml:lang="en">KuKanich, K.</dc:creator>
	<dc:creator xml:lang="en">Rankin, D.</dc:creator>
	<dc:creator xml:lang="en">Upchurch, D.</dc:creator>
	<dc:creator xml:lang="en">Comroe, A.</dc:creator>
	<dc:creator xml:lang="en">Crauer, B.</dc:creator>
	<dc:creator xml:lang="en">Berke, K.</dc:creator>
	<dc:creator xml:lang="en">Klocke, E. </dc:creator>
	<dc:creator xml:lang="en">Gonzalez, S.</dc:creator>
	<dc:creator xml:lang="en">Mason, D.</dc:creator>
	<dc:creator xml:lang="en">Orchard, R.</dc:creator>
	<dc:creator xml:lang="en">Jensen, G.</dc:creator>
	<dc:creator xml:lang="en">Cho, P.</dc:creator>
	<dc:creator xml:lang="en">Komp, M.</dc:creator>
	<dc:subject xml:lang="en">methadone</dc:subject>
	<dc:subject xml:lang="en">analgesia</dc:subject>
	<dc:subject xml:lang="en">post-operative</dc:subject>
	<dc:subject xml:lang="en">ovariohysterectomy</dc:subject>
	<dc:subject xml:lang="en">naltrexone</dc:subject>
	<dc:description xml:lang="en">Currently pain control in the perioperative setting is difficult due to the need for frequent injections of opioid drugs in dogs. A novel long-acting oral methadone formulation containing the human abuse/misuse deterrent naltrexone was evaluated in 43 dogs undergoing an ovariohysterectomy (OHE).</dc:description>
	<dc:publisher xml:lang="en">AAVPT Biennial Symposia</dc:publisher>
	<dc:date>2019-08-23</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://aavptbiennial-ojs-tamu.tdl.org/aavptbiennial/article/view/54</dc:identifier>
	<dc:source xml:lang="en">AAVPT Biennial Symposia; 21st Biennial Symposium; 35</dc:source>
	<dc:language>eng</dc:language>
	<dc:relation>https://aavptbiennial-ojs-tamu.tdl.org/aavptbiennial/article/view/54/48</dc:relation>
	<dc:rights xml:lang="en">Copyright (c) 2019 American Academy of Veterinary Pharmacology and Therapeutics</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		
